The S&P/ASX 200 Index (ASX: XJO) looks set to end the week in the red, but that’s not holding back these soaring ASX 200 ...
Piper Sandler analyst Michael S. Lavery upgraded Campbell Soup Company (NASDAQ:CPB) to Overweight from Neutral, raising the ...
Piper Sandler analyst Biren Amin lowered the firm’s price target on Allogene Therapeutics (ALLO) to $9 from $11 and keeps an Overweight ...
Fintel reports that on November 14, 2024, Piper Sandler upgraded their outlook for Campbell Soup (NasdaqGS:CPB) from Neutral ...
Piper Sandler believes that the overall uptrend in markets remains intact, despite a Wall Street rally triggered by Donald Trump's election win taking a bit of a breather this week.  The financial ...
The market ended Q3 on a high note, but the journey was turbulent with a ton of market-moving headlines. Click here to read ...
Piper Sandler upgraded Campbell (CPB) to Overweight from Neutral with a price target of $56, up from $47. The firm is citing better long-term ...